Author

Johannes Berges

Friedrich-Alexander-Universität Erlangen-NürnbergORCID 0000-0002-2613-0319Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:scRNA-seq· 1 Approach:simulation· 1 Approach:statistical model· 1

Frequent Co-Authors

Adrian WeichiD· 1 shared Carola BerkingiD· 1 shared Christopher LischeriD· 1 shared Cindy Flamann· 1 shared David Chambers· 1 shared Gerhard KrönkeiD· 1 shared Heiko BrunsiD· 1 shared Julio VeraiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperSystems Biology

Adrian WeichORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Systems BiologyJournal of Experimental & Clinical Cancer ResearchPeer-reviewedAug 4, 2025

The integration of network biology and pharmacophore modeling suggests repurposing Clindamycin as an inhibitor of pyroptosis via Caspase-1 blockage in tumor-associated macrophages

Adrian Weich, Johannes Berges, Cindy Flamann…·Julio Vera

The paper identifies Clindamycin as a potential inhibitor of pyroptosis in tumor-associated macrophages by integrating network biology and pharmacophore modeling.

5 citations

humanbulk RNA-seq

𝕏 PostBluesky